VANCOUVER, B.C.—EnWave Corporation announced the successful completion of tests using its recently developed powderREV technology in the dehydration of cultures and probiotics from Danisco BioActives. The tests were conducted as the first phase of an agreement signed with Danisco last year. The objective of the agreement is to create a dehydration method delivering high-speed continuous bulk powder processing capable of handling sensitive biological materials, such as cultures.
powderREV is a new Radiant Energy Vacuum (REV) process designed to convert a liquid stream of biological materials into bulk powder on a continuous basis. Preliminary tests on cultures were conducted at EnWave’s Vancouver lab using the single-vial REV prototype. Post-dehydration bioactivity levels from the REV dehydration methods show that REV-dried cultures are capable of achieving equivalent, or possibly better bioactivity for certain cultures than freeze-dried samples.
Based on the success of these early results, Danisco BioActives and EnWave will now undertake the second phase of the agreement to evaluate the commercial viability of EnWave’s powderREV dehydration technology on a wider scope.
The terms of the agreement grant Danisco with exclusivity for a limited period of time. Danisco BioActives and EnWave expect this second phase to be completed in the 2nd quarter of 2010.